Therapy Equipment has been acquired by ESAB Corporation
Owner Venture Managers has sold Therapy Equipment Ltd. to ESAB Corporation.
Founded in 1983, Therapy Equipment is a regional leader in the medical gas control market for suction and oxygen equipment. The business holds strong market leadership across the UK and the portfolio includes trusted suction equipment, flowmeters and medical regulators used in healthcare facilities across the region and internationally.
Headquartered in the US, ESAB Corporation is a leading global gas control company with supplier-of-choice brands across the world for the industrial, medical and specialty gas industries.
Owner Venture Managers is a venture capital and private equity company based in the UK. It partners and invests alongside a network of sector-focused operating partners, who are highest-caliber individuals with proven track records of profit improvement performance and acquisition-led growth in the relevant industry of the target entity.
Oaklins Cavendish, based in the UK, advised on the sale of Therapy Equipment to ESAB Corporation.
James Wooster
Director, Owner Venture Managers
Sprechen Sie mit dem Deal Team
Harry Radburn
Oaklins Cavendish
Transaktionen
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Mehr erfahrenGroupe JVS has completed an LBO with Capza and Bpifrance
The shareholders of Groupe JVS have completed an LBO with Capza and BpiFrance. Parquest sold their shares after partnering with the organization for three years. Groupe JVS’s management team will increase its ownership and remain as the majority shareholder of the group, alongside CAPZA and Bpifrance.
Mehr erfahrenCreo Medical Group plc has completed a US$15.7 million equity fundraise
Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.
Mehr erfahren